Rawal, S., Wildsmith, K. R., Aluri, J., Yagi, T., Chang, M., Niu, H., . . . Reyderman, L. (Jul-Sep2025). An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects. Alzheimer Disease & Associated Disorders, 39(3), 151-158.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Rawal, Sumit, et al. "An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects."
Alzheimer Disease & Associated Disorders 39, no. 3 (Jul-Sep2025): 151-158.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Rawal, Sumit, et al. "An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects."
Alzheimer Disease & Associated Disorders, vol. 39, no. 3, Jul-Sep2025, pp. 151-158.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.